Biomarker testing in colorectal cancer (CRC) informs doctors about unique features of cancer that may influence its growth, spread, recurrence, and treatment response. Colorectal cancer (CRC), which ...

Emerging discoveries in liquid biomarker research promise to transform the early detection, diagnosis and treatment monitoring of colorectal cancer (CRC), according to a new study, offering less ...

Despite significant advancements in medicine, cancer remains a major health challenge and the leading cause of mortality worldwide, highlighting the urgent need for continued research to identify ...

For decades, pathologists have diagnosed and graded breast cancer by looking at tissue samples under a microscope, searching ...

Metastatic breast cancer subtypes and biomarkers are crucial for guiding treatment decisions and managing disease progression. ER-positive, HER2-negative breast cancer treatment often begins with ...

Please provide your email address to receive an email when new articles are posted on . About a third of patients do not have a biomarker used to track treatment progress in pancreatic cancer. An AI ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

p16 Loss – a marker of Rb pathway inactivation – Identified as a Candidate Predictive Biomarker for KIF18A Inhibition Data Support Development Across Multiple Tumor Types and in Combination with ...

Recently validated markers have helped improve treatment but more are needed ...

Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a one-size-fits-all approach. Biomarkers serve diagnostic, prognostic, and predictive roles ...